Top
ALOX5‐5‐HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation
ALOX5‐5‐HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation
DOI: 10.1002/cam4.4066, Volume: 10, Issue: 15, Pages: 5246-5255
Article Type: research-article,
Article History
rev-recd:
received:
accepted:
published:
-
-
-
- Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.1002/cam4.4066&title=ALOX5‐5‐HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation&author=&keyword=[{keywordId=72, uniqueName=gastric-cancer, name=Gastric cancer, contentId=279145}, {keywordId=126, uniqueName=chemotherapy, name=Chemotherapy, contentId=279145}, {keywordId=64997, uniqueName=mek-erk, name=MEK/ERK, contentId=279145}, {keywordId=276515, uniqueName=alox5, name=ALOX5, contentId=279145}, {keywordId=340631, uniqueName=5‐hete, name=5‐HETE, contentId=279145}, {keywordId=340632, uniqueName=zileuton, last=true, name=zileuton, contentId=279145}],[{keywordId=72, uniqueName=gastric-cancer, name=Gastric cancer, contentId=279145}, {keywordId=126, uniqueName=chemotherapy, name=Chemotherapy, contentId=279145}, {keywordId=64997, uniqueName=mek-erk, name=MEK/ERK, contentId=279145}, {keywordId=276515, uniqueName=alox5, name=ALOX5, contentId=279145}, {keywordId=340631, uniqueName=5‐hete, name=5‐HETE, contentId=279145}, {keywordId=340632, uniqueName=zileuton, last=true, name=zileuton, contentId=279145}],[{keywordId=72, uniqueName=gastric-cancer, name=Gastric cancer, contentId=279145}, {keywordId=126, uniqueName=chemotherapy, name=Chemotherapy, contentId=279145}, {keywordId=64997, uniqueName=mek-erk, name=MEK/ERK, contentId=279145}, {keywordId=276515, uniqueName=alox5, name=ALOX5, contentId=279145}, {keywordId=340631, uniqueName=5‐hete, name=5‐HETE, contentId=279145}, {keywordId=340632, uniqueName=zileuton, last=true, name=zileuton, contentId=279145}],[{keywordId=72, uniqueName=gastric-cancer, name=Gastric cancer, contentId=279145}, {keywordId=126, uniqueName=chemotherapy, name=Chemotherapy, contentId=279145}, {keywordId=64997, uniqueName=mek-erk, name=MEK/ERK, contentId=279145}, {keywordId=276515, uniqueName=alox5, name=ALOX5, contentId=279145}, {keywordId=340631, uniqueName=5‐hete, name=5‐HETE, contentId=279145}, {keywordId=340632, uniqueName=zileuton, last=true, name=zileuton, contentId=279145}],[{keywordId=72, uniqueName=gastric-cancer, name=Gastric cancer, contentId=279145}, {keywordId=126, uniqueName=chemotherapy, name=Chemotherapy, contentId=279145}, {keywordId=64997, uniqueName=mek-erk, name=MEK/ERK, contentId=279145}, {keywordId=276515, uniqueName=alox5, name=ALOX5, contentId=279145}, {keywordId=340631, uniqueName=5‐hete, name=5‐HETE, contentId=279145}, {keywordId=340632, uniqueName=zileuton, last=true, name=zileuton, contentId=279145}],[{keywordId=72, uniqueName=gastric-cancer, name=Gastric cancer, contentId=279145}, {keywordId=126, uniqueName=chemotherapy, name=Chemotherapy, contentId=279145}, {keywordId=64997, uniqueName=mek-erk, name=MEK/ERK, contentId=279145}, {keywordId=276515, uniqueName=alox5, name=ALOX5, contentId=279145}, {keywordId=340631, uniqueName=5‐hete, name=5‐HETE, contentId=279145}, {keywordId=340632, uniqueName=zileuton, last=true, name=zileuton, contentId=279145}],&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova